Astoriom Appoints New Chief Financial Officer Jack Grimshaw

Astoriom, a leading company in Stability Storage for the pharma industry, is pleased to announce the appointment of Jack Grimshaw as its new Chief Financial Officer (CFO)

by Maria Buitrago | Thursday 20 June 2024

Jack Grimshaw CFO Astoriom
Jack brings a wealth of experience and expertise in high-growth financial management, having previously held significant roles in both established and startup environments.

Jack Grimshaw joins Astoriom from Maxwellia, where he was instrumental in the company's commercial setup and product launches. At Maxwellia, Jack led the finance and supply chain teams, successfully raising funding from a range of institutional and high net worth investors.

His role was crucial in transitioning prescription products to over-the-counter availability, with the business notably launching one of the first oral contraceptive pills available without prescription in the UK.

Prior to Maxwellia, Jack headed the pharmacy and healthcare finance team at Sainsbury's, overseeing the growth of the business to 281 sites before its acquisition by Lloyds. His tenure at Sainsbury's highlighted his ability to scale businesses organically and through acquisitions, demonstrating a strong track record in driving profitability and successful exits. Details about his role at Sainsbury's and transition to Maxwellia can be seen here.

Experience and Expertise

Jack’s career spans across major retailers and SME sectors, with notable positions at Sainsbury's, Dorothy Perkins, Burton at the Arcadia Group, and Co-op. His expertise lies in scaling businesses to profitability, managing high-growth phases, and leading financial strategies. Jack’s leadership style is described as open, collaborative, and proactive, emphasizing leading from the front and fostering team growth.

Vision for Astoriom

In the ever-evolving pharma industry, Jack's appointment is set to boost Astoriom’s competitive edge. In his new role at Astoriom, Jack is set to focus on expanding the company’s core growth area in biorepository services. He aims to enhance Astoriom's footprint within high-value pharmaceutical and biologic markets through a buy-and-build growth strategy in the US and European markets.

“We aim to scale Astoriom’s operations significantly by enhancing our product base, our biorepository services, expanding our geographical footprint, and focusing on high-value markets” said Jack. “Our goal is to build on our existing systems and processes to fuel growth and deliver exceptional value to our shareholders.”

Personal Touch

Outside of his professional life, Jack is family-oriented and enjoys staying active through cycling and gym workouts. His commitment to balancing work and family reflects in his leadership approach, fostering a supportive and dynamic work environment.

About Astoriom

Astoriom is headquartered in Rochdale, with additional sites in Ireland and the US. Offers a full range of Stability Storage and Service and Validation Solutions, including photostability, disaster recovery and thermal cycling. With a new suite of systems and a robust leadership team, Astoriom is poised for significant growth and innovation in the coming years.


Maria Buitrago
+44 1706 716710

Thursday 20 June 2024 / file under Biotechnology | Healthcare | Medical | Pharmaceuticals